echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Research on digital development of biomedical industry in China

    Research on digital development of biomedical industry in China

    • Last Update: 2019-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On April 22, 2018, general secretary Xi Jinping pointed out in his congratulatory letter to the first digital China Construction Summit that we should cultivate new kinetic energy with information, promote new development with new kinetic energy, and create new resplendence with new development In May 26th, general secretary Xi Jinping sent a congratulatory letter to the 2018 China international big data industry expo, emphasizing the importance of grasping the important opportunities for the development of big data and promoting the healthy development of big data industry In August 23rd, general secretary Xi Jinping made clear the important plan of accelerating the industrialization of digital and digitalization of industries in the congratulation letter to the first China International Intelligent Industry Expo, which pointed out the way forward for speeding up the development of digital economy in China 1、 To speed up the digital industrialization and industrial digitalization is the action path of high-quality development industrial digitalization Simply speaking, it is to use modern digital information technology to transform traditional industries in an all-round, all-round and all chain way The research results show that for every 10% increase in digitalization, the per capita GDP increases by 0.5% to 0.62% Industrial digitalization is becoming an important engine to promote the sustainable development of economy by promoting the deep integration of Internet, big data, artificial intelligence and real economy and improving total factor productivity Since the eighteen Party's Congress, the Party Central Committee with Comrade Xi Jinping as its core has upgraded the digital economy into a national strategy, accelerating the development of the digital economy, speeding up the promotion of digital industrialization and industrial digitalization as an important action path for the development of social and economic quality In 2018, driven by the policies of the CPC Central Committee, China's digital economy and industrial digitalization developed rapidly On October 27, 2018, Shanghai Academy of Social Sciences officially released the blue book of 2018 global digital economy competitiveness development report From four aspects of digital infrastructure, digital industry, digital innovation and digital governance, the blue book uses 11 secondary indicators and 22 tertiary indicators to measure the competitiveness of the global digital economy in 50 countries The final ranking shows that in 2018, the United States has an absolute advantage in the development of global digital economy with a total score of 84.24, ranking the top in four sub items China's competitiveness score is 63.05, ranking second In the single dimension of digital industry, China's strength is relatively close to that of the United States, with strong momentum 2、 The current situation of the development of China's biomedical industry China's bioeconomy is accelerating to become an important new economic form In China's 13th five year plan for the development of national strategic emerging industries, bioeconomy has been listed as one of the five goals of China's 13th five year plan for the development of strategic emerging industries, and a new goal of "accelerating bioeconomy to become an important new economic form after information economy" has been put forward The 13th five year plan for the development of biological industry has determined the detailed action route for the development of biological industry in China, and established the development goal of "seven directions, six projects and three platforms" Up to now, more than 50 of the 168 high-tech zones in China have listed biomedical industry as the first industry, and the development upsurge of biomedical industry has been raised all over the country By the end of 2018, the number of enterprises in the field of life and health, including biomedicine, has exceeded 1.92 million, and China's biomedical industry is ushering in an unprecedented era of innovation under this macro trend With the launch of such heavy policies as precision medical strategy, generic drug consistency evaluation, drug listing holder system, CFDA's accession to ICH, 36 (opinions on deepening the reform of review and approval system to encourage innovation of pharmaceutical medical devices), the domestic bioeconomy industry is experiencing a Nirvana road from made in China to created in China, and from imitation to innovation Big data of China's life and health industry III The necessity of digitalization of biomedical industry (I) the accelerated transition from industrial economy to digital economy in the world with the extensive and in-depth application of Internet, big data, artificial intelligence and other technologies, the continuous emergence of new models and formats of global economy, and profound changes in the way of production and life of human society The transformation from industrial economy to digital economy is characterized by the reconstruction of production factors with data as the core, and the transformation from the economic development mode dominated by material production and material services to the economic development mode dominated by information production and information services (2) The historical experience that data has become a new engine of new factors driving economic and social development shows that every major change in economic form will inevitably give birth to and must rely on new production factors Labor force and land are new production factors in the era of agricultural economy, and capital and technology are new production factors in the era of industrial economy In the era of digital economy, data is becoming a key factor of production and a new engine driving economic and social development On the one hand, big data has become the basic strategic resources of the society, which contains huge potential and energy Today, more than 95% of human information is stored, transmitted and used in digital format With the rapid development of data storage and computing capacity, the potential of data value creation has been greatly enhanced On the other hand, the convergence and integration of data resources and industries is promoting a new leap in social productivity Data flow, material flow and capital flow integration and coordination capabilities help greatly improve the efficiency and level of optimizing resource allocation (3) Digitalization is the inevitable requirement of the miniaturization of innovation and Entrepreneurship of biomedical industry, which has the characteristics of high innovation cost, high investment risk and long R & D cycle The development experience of biomedical industry in developed countries shows that with the miniaturization of biomedical innovation and entrepreneurship team, large-scale collaborative development is an inevitable path, and industrial digitalization is the basis for the realization of efficient collaboration in the industrial chain Only through industry digitalization, continuous improvement of innovation efficiency and market transaction efficiency of biomedical industry, and reduction of transaction cost, can enterprises reduce the organizational scale, break through the organizational boundary, quickly and efficiently obtain the required resources and services through the industrial chain 4、 The path and way of digitalization of biomedical industry (1) the three stages of digitalization of biomedical industry are divided into three stages: resource digitalization, collaborative networking and industrial intelligence Resource digitization stage: Digitalization and information transformation of industrial infrastructure and resources; collaborative networking stage: dynamic allocation of resources on demand in a large range, online transaction, service and collaboration of upstream and downstream of the industrial chain; Industrial intelligence stage: the advanced stage of industrial digitalization, which is mainly based on the laws of industrial development and the personalized needs of different industrial entities to deeply mine and intelligently allocate resources, and finally realize industrial intelligence The three stages of the digitalization of biomedical industry (2) based on digitalization, the open value ecology of biomedical industry is based on digitalization, which is mainly manifested in more accurate mining of user needs, more dynamic integration and allocation of resources and network-based industrial chain cooperation Specifically including the following aspects: 1 Find out the background and support decision-making Based on big data, around the development elements of enterprises, capital, talents, etc., an all-round and multi angle industrial map is formed to find out the background, find out the short board, and provide support for industrial planning and decision-making; 2 Promote industrial agglomeration Attract the gathering of biomedical R & D services, production and manufacturing, science and technology finance and other elements, accurately match the market supply and demand, improve the supply side efficiency and the overall coordination efficiency of the industrial chain, and ensure the implementation of industrial planning; 3 Support innovation and entrepreneurship Help biomedical innovation and entrepreneurship enterprises to quickly establish product service supply chain, accurately obtain cost-effective service resources, expert talents and information intelligence, and accelerate the transformation of innovation achievements (3) Industrial innovation service platform is the tangible carrier of building industrial innovation service platform and enabling industrial open value ecology for SMEs Based on the platform to gather industrial resources, through data intelligence and network collaboration, realize the dynamic allocation of industrial resources on demand, and comprehensively empower the innovation and entrepreneurship enterprises, especially small and medium-sized micro enterprises and individuals in the field of biomedicine The online platform establishes an Internet platform with digital service resources as the starting point and the connection between the supplier and the demander The offline platform serves the whole process of innovation and Entrepreneurship of biomedical industry in an all-round way with the entity landing and platform operation as the carrier, helping it quickly and accurately obtain cost-effective service resources, expert talents, information intelligence and technical training in this region and in the whole world Meanwhile, we should quickly establish a complete business system, accelerate the transformation of innovation achievements, and improve business efficiency The function and value of the service platform for entrepreneurship and innovation small and medium-sized innovation and entrepreneurship enterprises urgently need to obtain more abundant resources and services, so as to break the technical and interest barriers built by large enterprises Therefore, the small and medium-sized micro enterprises should be taken as the application subject of innovation service platform in the biomedical industry development cluster or industrial park to help them reduce the cost of industrial resource acquisition and improve the efficiency of R & D and production and other business activities in the process of technology R & D and production and operation 5、 The digitalization of biomedical industry needs the government's promotion (1) it needs the mechanism innovation of industry competent departments and the promotion of industry digitalization It is not only the penetration and integration of Internet, big data, artificial intelligence and other technologies in the industry, but also the innovation of industrial planning, strategy, organization, process and business model The research results of Huoshi innovation on the leading countries and regions in the world's biomedical industry show that the global biomedical industry is in the trend of agglomeration development The cluster development of biomedical industry requires the competent industrial departments to continuously improve the coordination of production relations and productivity, improve the regional industrial chain cooperation and external resource acquisition capacity through policy innovation, and constantly expand the scope, capacity and effectiveness of the dynamic allocation of resources required for industrial development Development trend of global biomedical industry cluster The construction of new industrial ecosystem system is a long-term evolution process Therefore, the construction and application of innovation service platform can not be achieved overnight It requires the joint efforts of government industry authorities and the market, through the construction and promotion of mechanism innovation organization platform in biopharmaceutical industry cluster areas, parks and other regions, and through government purchase of services and other ways to encourage SMEs to Use platform At the same time, the platform itself needs to be promoted by a large number of small and medium-sized micro enterprises to continue to iterate and improve rapidly, and finally form a spiral development mode from exploration to maturity (2) Improving the credit system and building a new environment for resource sharing, the digitalization of industrial resources can better solve the problem of information asymmetry However, if the credit system is not perfect, the online transaction of resources and capabilities is still difficult to achieve In order to realize the dynamic allocation of resources on demand, it is necessary to establish a reliable new mechanism for credit sharing among the participants Therefore, the competent government departments are required to take measures to integrate industry-related credit information resources, accelerate credit information interconnection and integration sharing, establish a new mechanism of credit co construction and sharing to promote the dynamic and optimized allocation of industrial resources, strengthen credit service and supervision for industry-related subjects, and provide online service delivery Yida provides credit guarantee to create a good environment for the innovation and rapid development of biomedical industry (3) Further promote "mass entrepreneurship and innovation", promote the development of biomedical R & D industry digitalization, greatly improve the efficiency of internal resource allocation and reduce the internal transaction rate of enterprises
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.